Upgrade to SI Premium - Free Trial

Harmony Biosciences Holdings Inc. (HRMY) PT Lowered to $70 at Oppenheimer

August 4, 2026 2:30 PM
(Updated - August 4, 2026 2:30 PM EDT)

Oppenheimer analyst Andreas Argyrides lowered the price target on Harmony Biosciences ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change